UBLITUXIMAB AND IBRUTINIB FOR PREVIOUSLY TREATED GENETICALLY HIGH‐RISK CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF THE GENUINE PHASE 3 STUDY
暂无分享，去创建一个
S. Kambhampati | J. Burke | I. Flinn | D. Brander | A. Mato | J. Chandler | F. Lansigan | S. Lunin | M. Schreeder | M. Shtivelband | N. Ghosh | H. Miskin | P. Travis | A. Zweibach | K. Kolibaba | J. Sharman | M. Weiss | P. Sporteli